Asymmetric dimethylarginine levels and diabetes duration: Relationship with measures of subclinical atherosclerosis and cardiac function in children and adolescents with Type 1 diabetes

ERSOY, BETÜL; Eroglu, Nilgun; Cetin, Mecnun; ONUR, ECE; ÖZKOL, MİNE; COŞKUN, ŞENOL

doi:10.1177/1479164118757921

Asymmetric dimethylarginine levels and diabetes duration: Relationship with measures of subclinical atherosclerosis and cardiac function in children and adolescents with Type 1 diabetes

ERSOY B., Eroglu N., Cetin M., ONUR E., ÖZKOL M., COŞKUN Ş.

DIABETES & VASCULAR DISEASE RESEARCH, cilt.15, sa.3, ss.196-203, 2018 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 15 Sayı: 3
Basım Tarihi: 2018
Doi Numarası: 10.1177/1479164118757921
Dergi Adı: DIABETES & VASCULAR DISEASE RESEARCH
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.196-203
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Karadeniz Teknik Üniversitesi Adresli: Evet

Özet

Aims: We aimed to evaluate asymmetric dimethylarginine levels in young patients with Type 1 diabetes mellitus according to diabetes duration and to examine the relationship between these levels and measures of atherosclerosis and myocardial function.